RecruitingNCT07550400

Role of Echocardiography and Ultrasound Indices in Resuscitation of Septic Shock Patients

Echocardiographic Left Ventricular End Diastolic Area Versus Carotid Artery Duplex as a Sensitive Indicator for Guiding Fluid Resuscitation in Septic Shock Patients . A Prospective Cohort Study


Sponsor

Ain Shams University

Enrollment

40 participants

Start Date

May 3, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Fluid replacement is considered the cornerstone of hemodynamic management in critically ill patients especially in patients with septic shock. However, only about 50% of critically ill hemodynamically unstable patients are responsive to fluids. Consequently, the resuscitation of critically ill patients requires an accurate assessment of the patients' intravascular volume status and their volume responsiveness. In this study, we will compare the efficacy of carotid artery flow to echo left ventricular end diastolic volume as a predictive value for fluid resuscitation in septic shock patients.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria9

  • ▪ Age:18-50 years old
  • Sex: both males \&females.
  • Patients diagnosed with septic shock according to SOFA score more than or equal 1
  • Presence of at least one sign of acute circulatory failure from:
  • Low blood pressure (mean arterial pressure <65 mmHg and / or systolic <90 mmHg).
  • Tachycardia> 120 bpm without other obvious cause of circulatory failure.
  • Oliguria <1 ml / kg during the last hour suggestive of circulatory failure.
  • Blood hyperlactatemia > 2mmol / l without other obvious cause a systemic circulatory failure.
  • Another sign justifying, for example vascular increase capillary refill time more than 2 seconds.

Exclusion Criteria7

  • ▪ Known significant valvular heart disease (sever aortic insufficiency or stenosis)
  • Known carotid artery stenosis >50% or previous carotid surgery
  • Clear contraindication to the carotid artery Doppler such as wound or infection or complete or partial occlusion of the carotid artery.
  • Arrhythmias affect stroke volume assessment (atrial fibrillation, frequent PVCs)
  • Dilated cardiomyopathy.
  • Poor transthoracic echocardiographic window
  • Patient refusal

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcarotid artery duplex

, Carotid Doppler (T0) will be performed within 1-2 Hours of ICU Admission to measure the following parameters: "Peak systolic velocity" and Velocity Time Integral over the common carotid artery. Using the linear probe (VF12-4) of ultrasound machine (ACUSON NX3, Siemens Medical solution USA, Inc.) * According to surviving sepsis campaign guidelines 2021, patients diagnosed with septic shock should be given 30ml/kg IV crystalloid fluid within the first 3 hours, the fluid will be given in the form of 500 ml boluses, each bolus should be given in 15 minutes. * FC "fluid challenge" will be performed by rapid volume infusion over (30minutes) of 1000mL Ringer acetate solution. * Carotid artery Duplex parameters will be repeated. Relative changes in "Peak Systolic Velocity, Velocity Time integral" will be expressed in

PROCEDURELeft ventricular end diastolic area

* Echocardiography (T0) will be performed within 1-2 Hours of ICU Admission to measure LVEDA if less than 10 cm2 then the patient will be considered hypovolemic. * According to surviving sepsis campaign guidelines 2021, patients diagnosed with septic shock should be given 30ml/kg IV crystalloid fluid within the first 3 hours, the fluid will be given in the form of 500 ml boluses, each bolus should be given in 15 minutes. * FC "fluid challenge" will be performed by rapid volume infusion over (30minutes) of 1000mL Ringer acetate solution. * After five minutes from FC "fluid challenge" (T1), echocardiography will be repeated to re-measure LVEDA. Pt will be defined as a responder if LVEDA b


Locations(1)

Faculty of medicine, Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07550400


Related Trials